Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dupixent
Dupixent
Sanofi's Dupixent scores big as the first FDA-approved treatment for eosinophilic esophagitis
Fierce Pharma
Sun, 05/22/22 - 09:15 pm
Sanofi
Regeneron
Dupixent
FDA
eosinophilic esophagitis
FDA accepts Regeneron, Sanofi’s Dupixent for priority review
Pharmaceutical Business Review
Tue, 04/5/22 - 10:53 am
Regeneron
Sanofi
Dupixent
FDA
eosinophilic esophagitis
Lilly, after making $1B bet, posts 'compelling' late-phase data on Dupixent rival
Fierce Biotech
Mon, 03/28/22 - 10:20 am
Eli Lilly
lebrikizumab
Demira
Sanofi
Regeneron
Dupixent
atopic dermatitis
Sanofi chases fourth Dupixent nod after late-stage eosinophilic esophagitis trial win
Fierce Pharma
Mon, 02/28/22 - 11:42 pm
Sanofi
Regeneron
eosinophilic esophagitis
Dupixent
clinical trials
Sanofi's Dupixent falls short in phase 3 chronic spontaneous urticaria trial
Pharmaforum
Fri, 02/18/22 - 10:40 am
Sanofi
Regeneron
clinical trials
Dupixent
chronic spontaneous urticaria
Sanofi's Dupixent rolls on, but US flu shots took backseat to COVID-19 boosters in the fourth quarter
Fierce Pharma
Fri, 02/4/22 - 01:06 pm
Sanofi
Dupixent
earnings
COVID-19
Leo puts target on Dupixent in US as FDA clears tralokinumab
Pharmaforum
Thu, 12/30/21 - 10:45 am
Sanofi
Regeneron
Dupixent
tralokinumab
FDA
With Sanofi's mighty Dupixent chasing behind, Takeda's Eohilia suffers FDA rejection after mysterious delay
Fierce Pharma
Wed, 12/22/21 - 11:11 am
Takeda
Eohilia
Sanofi
Dupixent
FDA
eosinophilic esophagitis
Connect Biopharma celebrates a mid-stage win for its Dupixent rival, but shares tank after investors clamor for data
Endpoints
Fri, 12/17/21 - 10:52 am
Connect Biopharma
Dupixent
China
eczema
clinical trials
Sanofi, Regeneron plot Dupixent filing in young eczema patients, advancing drug's megablockbuster ambitions
Fierce Pharma
Mon, 12/13/21 - 11:04 am
Sanofi
Regeneron
Dupixent
eczema
pediatric
November sees Sanofi-Regeneron dethroned after 6-month rule over top TV ad spender list
Fierce Pharma
Sun, 12/5/21 - 10:45 pm
Sanofi
Regeneron
Dupixent
DTC advertising
television ads
Connect Biopharma celebrates a mid-stage win for its Dupixent rival, but shares tank after investors clamor for data
Endpoints
Fri, 11/19/21 - 11:10 am
Connect Biopharma
China
eczema
clinical trials
CBP-201
Dupixent
Sanofi's €10B sales target for Dupixent? The 'megabrand' is more than halfway there, exec says
Fierce Pharma
Thu, 10/28/21 - 10:57 am
Sanofi
Dupixent
earnings
Sanofi, Regeneron gear up for new Dupixent filing after clearing second PhIII for eosinophilic esophagitis
Endpoints
Mon, 10/25/21 - 10:48 am
Sanofi
Regeneron
Dupixent
eosinophilic esophagitis
clinical trials
Dupixent scores a first in rare skin disease prurigo nodularis
Pharmaforum
Fri, 10/22/21 - 11:22 am
Sanofi
Regeneron
Dupixent
prurigo nodularis
Pfizer's abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, but key questions remain
Fierce Biotech
Mon, 08/30/21 - 11:03 am
Pfizer
abrocitinib
atopic dermatitis
Dupixent
Sanofi
Regeneron
clinical trials
Lilly, swinging at the king, shows Dupixent rival works in phase 3, but wait for key figures goes on
Fierce Biotech
Mon, 08/16/21 - 12:25 pm
Eli Lilly
lebrikizumab
Sanofi
Regeneron
Dupixent
atopic dermatitis
clinical trials
Sanofi and Regeneron solidify Dupixent TV ad lead, topping July pharma spenders again, trailed by AbbVie and Novo Nordisk
Fierce Pharma
Fri, 08/6/21 - 12:22 pm
DTC advertising
television ads
Dupixent
Regeneron
Sanofi
Lilly’s lebrikizumab looks to outdo Dupixent
EP Vantage
Mon, 08/2/21 - 10:48 am
Eli Lilly
lebrikizumab
atopic dermatitis
Dupixent
Sanofi
Regeneron
New Drug Proves to Ease the Itch for Chronic Spontaneous Urticaria
BioSpace
Sat, 07/31/21 - 10:18 pm
Regeneron
Sanofi
Dupixent
clinical trials
chronic spontaneous urticaria
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »